Peder Søndergaard Madsen

Title: Peder Søndergaard Madsen: Innovator in Neuropharmacology

Introduction

Peder Søndergaard Madsen is a notable inventor based in Risskov, Denmark. He has made significant contributions to the field of neuropharmacology, particularly through his innovative work on specific ligands related to the protein Sortilin. His research aims to advance the treatment of various neurological disorders.

Latest Patents

Madsen holds a patent for "Specific ligands to sortilin." This invention provides a Sortilin crystal and methods for growing said crystal. Furthermore, it offers methods for designing specific ligands based on the crystal structure of Sortilin. The invention also relates to the preparation and use of such ligands for developing a medicament aimed at treating diseases, damage, or disorders of the central and peripheral nervous systems. He has 1 patent to his name.

Career Highlights

Peder Søndergaard Madsen is associated with H. Lundbeck A/S, a prominent pharmaceutical company specializing in brain diseases. His work at Lundbeck has allowed him to focus on innovative solutions for treating neurological conditions, contributing to the company's mission of improving the quality of life for patients.

Collaborations

Madsen has collaborated with esteemed colleagues such as Jens Claus Munck Petersen and Poul Nissen. These partnerships have fostered a collaborative environment that enhances research and development in the field of neuropharmacology.

Conclusion

Peder Søndergaard Madsen is a distinguished inventor whose work on Sortilin ligands has the potential to revolutionize treatments for neurological disorders. His contributions to the field underscore the importance of innovation in medicine.